Literature DB >> 24613890

Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Jaafar El Annan, Petros E Carvounis.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24613890      PMCID： PMC3980167          DOI： 10.1097/IIO.0000000000000027

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  69 in total

1.  Comparison of clinical outcomes and wound dynamics of sclerotomy ports of 20, 25, and 23 gauge vitrectomy.

Authors:  Manish Nagpal; Sharang Wartikar; Kamal Nagpal
Journal:  Retina       Date:  2009-02       Impact factor: 4.256

2.  Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.

Authors:  John O Mason; Cheri T Colagross; Troy Haleman; Jeffrey J Fuller; Milton F White; Richard M Feist; Tracy L Emond; Gerald McGwin
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

3.  Vitreous contraction in proliferative diabetic retinopathy.

Authors:  M D Davis
Journal:  Arch Ophthalmol       Date:  1965-12

4.  Vitrectomy: a pars plana approach.

Authors:  R Machemer; H Buettner; E W Norton; J M Parel
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 Jul-Aug

5.  Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.

Authors:  J F West; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

6.  Microproliferations in proliferative diabetic retinopathy and their relationship to the vitreous: corresponding light and electron microscopic studies.

Authors:  J Faulborn; S Bowald
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

7.  Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.

Authors:  Mohammed K Khuthaila; Jason Hsu; Allen Chiang; Francis Char DeCroos; Eugene A Milder; Vikram Setlur; Sunir J Garg; Marc J Spirn
Journal:  Am J Ophthalmol       Date:  2013-01-11       Impact factor: 5.258

8.  Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

Authors:  R Meyer-Schwickerath; A Pfeiffer; W F Blum; H Freyberger; M Klein; C Lösche; R Röllmann; H Schatz
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  23-gauge sutureless vitrectomy and 20-gauge vitrectomy: a case series comparison.

Authors:  A Misra; G Ho-Yen; R L Burton
Journal:  Eye (Lond)       Date:  2008-06-06       Impact factor: 3.775

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  14 in total

1.  Cytokines associated with hemorrhage in proliferative diabetic retinopathy.

Authors:  Ho Ra; Anna Lee; Junhyuck Lee; Inkee Kim; Jiwon Baek
Journal:  Int Ophthalmol       Date:  2021-02-20       Impact factor: 2.031

2.  Widefield Swept-Source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage: A Prospective Study.

Authors:  Ying Cui; Ying Zhu; Edward S Lu; Rongrong Le; Inês Laíns; Raviv Katz; Jay C Wang; Itika Garg; Yifan Lu; Rebecca Zeng; Dean Eliott; Demetrios G Vavvas; Deeba Husain; Joan W Miller; Leo A Kim; David M Wu; John B Miller
Journal:  Ophthalmology       Date:  2021-02-26       Impact factor: 14.277

3.  Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy.

Authors:  Erkan Celik; Ozkan Sever; Fatih Horozoglu; Ates Yanyalı
Journal:  Clin Ophthalmol       Date:  2016-05-17

4.  Altered spontaneous brain activity patterns in diabetic patients with vitreous hemorrhage using amplitude of low‑frequency fluctuation: A resting‑state fMRI study.

Authors:  Wen-Qing Shi; Li-Ying Tang; Qi Lin; Biao Li; Nan Jiang; Pei-Wen Zhu; Qing Yuan; Lei Ye; Yi Shao
Journal:  Mol Med Rep       Date:  2020-07-03       Impact factor: 2.952

5.  The Role of Head Elevation in Treatment of Vitreous Haemorrhage.

Authors:  Pear Pongsachareonnont; Nattadet Rattana-Aram; Thanapong Somkijrungroj
Journal:  Clin Ophthalmol       Date:  2020-01-07

Review 6.  Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy.

Authors:  Arunbalaji Pugazhendhi; Margaret Hubbell; Pooja Jairam; Balamurali Ambati
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

7.  Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.

Authors:  Baojie Hou; Yifei Huang; Qun Wang; Jie Zhao; Qing Xu; Cui Han
Journal:  BMC Ophthalmol       Date:  2021-03-09       Impact factor: 2.209

8.  Fibroblast Growth Factor Type 1 Ameliorates High-Glucose-Induced Oxidative Stress and Neuroinflammation in Retinal Pigment Epithelial Cells and a Streptozotocin-Induced Diabetic Rat Model.

Authors:  Hsin-Wei Huang; Chung-May Yang; Chang-Hao Yang
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

9.  Comparison of montage with conventional stereoscopic seven-field photographs for assessment of ETDRS diabetic retinopathy severity.

Authors:  Nam V Nguyen; Erin M Vigil; Muhammad Hassan; Muhammad S Halim; Sean C Baluyot; Hugo A Guzman; Rubbia Afridi; Diana V Do; Yasir J Sepah
Journal:  Int J Retina Vitreous       Date:  2019-12-13

Review 10.  Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage.

Authors:  Ahmad M Mansour; Mohammed Ashraf; Khalil M El Jawhari; Michel Farah; Ahmed Souka; Chintan Sarvaiya; Sumit Randhir Singh; Alay Banker; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2020-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.